Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200083 · ClinicalTrials.gov registry record · NA
Study of Weight Loss Using Gastric Stimulation in Obese Patients
A NA study, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT00200083: Completed NA study, sponsored by MedtronicNeuro.
NCT00200083 is a NA study that has completed, run by MedtronicNeuro. The registered enrollment target is 190 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00200083, a NA study, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effect of an implanted device that stimulates the stomach to help obese patients lose weight.
Interventions
- DEVICE Transcend II Model 8848
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2004-05 |
| Est. Completion | 2008-01 |
| Phase | NA |
What the finished NCT00200083 record still lists
NCT00200083 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Transcend II Model 8848 is the first listed.
NCT00200083 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00200083 about?
NCT00200083 is a clinical study titled "Study of Weight Loss Using Gastric Stimulation in Obese Patients". The purpose of this study is to test the effect of an implanted device that stimulates the stomach to help obese patients lose weight.
What is the current status of trial NCT00200083?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2004-05. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00200083?
The interventions under investigation include: Transcend II Model 8848 (DEVICE).
Who is sponsoring clinical trial NCT00200083?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00200083's enrollment target sits among peer trials
190 574th of 2000 higher than 1,425 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia